Long-term safety profile of pembrolizumab monotherapy and relationship with clinical outcome: A pooled analysis of patients with advanced melanoma

被引：1

作者：

Hamid, O. ^{[1
]}

Joshua, A. M. ^{[2
]}

Hwu, W-J. ^{[3
]}

Ribas, A. ^{[4
]}

Weber, J. ^{[5
]}

Daud, A. S. ^{[6
]}

Hodi, F. S. ^{[7
]}

Wolchok, J. D. ^{[8
]}

Mitchell, T. C. ^{[9
]}

Hersey, P. ^{[10
]}

Dronca, R. ^{[11
]}

Joseph, R. W. ^{[12
]}

Boutros, C. ^{[13
]}

Min, L. ^{[14
,15
]}

Long, G. V. ^{[16
]}

Schachter, J. ^{[17
]}

Lin, J. ^{[18
]}

Ibrahim, N. ^{[18
]}

Carlino, M. ^{[10
]}

Robert, C. ^{[13
]}

机构：

[1] Angeles Clin & Res Inst, Dept Oncol, Los Angeles, CA USA

[2] St Vincents Hosp, Kinghorn Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia

[3] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA

[4] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA

[5] NYU Langone Hlth, Perlmutter Canc Ctr, Med Oncol, New York, NY USA

[6] UCSF, Dept Hematol Oncol, San Francisco, CA USA

[7] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[8] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

[9] Penn Med, Abramson Canc Ctr, Div Hematol & Oncol, Philadelphia, PA USA

[10] Univ Sydney, Dept Med, Sydney, NSW, Australia

[11] Mayo Clin, Dept Med Oncol, Rochesterd, MN USA

[12] Mayo Clin, Dept Hematol Oncol, Jacksonville, FL 32224 USA

[13] Gustave Roussy, Serv Dermatol, Dept Oncol, Villejuif, France

[14] Brigham & Womens Hosp, Med Oncol, 75 Francis St, Boston, MA 02115 USA

[15] Harvard Med Sch, Boston, MA 02115 USA

[16] Univ Sydney, Dept Med, Wollstonecraft, Australia

[17] Chaim Sheba Med Ctr, Div Oncol, Tel Hashomer, Israel

[18] Merck & Co Inc, Med Oncol, Kenilworth, NJ USA

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.1262

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1139P

引用

页码：S762 / S763

页数：2

共 50 条

[1] Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma
Robert, Caroline
Hwu, Wen-Jen
Hamid, Omid
Ribas, Antoni
Weber, Jeffrey S.
Daud, Adil, I
Hodi, F. Stephen
Wolchok, Jedd D.
Mitchell , Tara C.
Hersey, Peter
Dronca, Roxana
Joseph, Richard W.
Boutros, Celine
Min, Le
Long, Georgina, V
Schachter, Jacob
Puzanov, Igor
Dummer, Reinhard
Lin, Jianxin
Ibrahim, Nageatte
Diede, Scott J.
Carlino, Matteo S.
Joshua, Anthony M.
EUROPEAN JOURNAL OF CANCER, 2021, 144 : 182 - 191
[2] Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma
Weber, Jeffrey S.
Hodi, F. Stephen
Wolchok, Jedd D.
Topalian, Suzanne L.
Schadendorf, Dirk
Larkin, James
Sznol, Mario
Long, Georgina V.
Li, Hewei
Waxman, Ian M.
Jiang, Joel
Robert, Caroline
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 785 - +
[3] Long-term pooled safety analysis of tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers
Zhou, Caicun
Meyer, Tim
Huang, Rose
Yuan, Yuan
Schnell, Patrick
Wu, John
Kadva, Alysha
Mehmeti, Jola
Ajani, Jaffer A.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[4] Long-term outcome of patients with advanced melanoma
Parolin, V.
Nortilli, R.
Strina, C.
Sabbioni, R.
Sava, T.
Cetto, G. L.
EJC SUPPLEMENTS, 2007, 5 (04): : 400 - 401
[5] A POOLED ANALYSIS OF 655 PATIENTS WITH ADVANCED MELANOMA ENROLLED IN KEYNOTE-001: LONG-TERM EFFICACY OF PEMBROLIZUMAB (MK-3475)
Daud, A.
Joshua, A. M.
Ribas, A.
Robert, C.
Hodi, F. S.
Wolchok, J.
Hwu, W-J
Weber, J. S.
Gangadhar, T. C.
Joseph, R.
Dronca, R.
Patnaik, A.
Zarour, H.
Kefford, R.
Lindia, J.
Li, X. N.
Ebbinghaus, S.
Kang, S. P.
Hamid, O.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 43 - 43
[6] Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
Sznol, Mario
Ferrucci, Pier Francesco
Hogg, David
Atkins, Michael B.
Wolter, Pascal
Guidoboni, Massimo
Lebbe, Celeste
Kirkwood, John M.
Schachter, Jacob
Daniels, Gregory A.
Hassel, Jessica
Cebon, Jonathan
Gerritsen, Winald
Atkinson, Victoria
Thomas, Luc
McCaffrey, John
Power, Derek
Walker, Dana
Bhore, Rafia
Jiang, Joel
Hodi, F. Stephen
Wolchok, Jedd D.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) : 3815 - +
[7] Long-Term Efficacy and Safety of Teriflunomide: An Analysis of Pooled Clinical Trials
Macdonell, R.
Freedman, M. S.
Ramio-Torrenta, L.
Zaffaroni, M.
De Seze, J.
Ahn, S.
Miller, A. E.
Kallmann, B.
Rog, D.
Benamor, M.
Truffinet, P.
Chavin, J.
Poole, E.
Lebrun-Frenay, C.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 472 - 473
[8] Long-Term Efficacy and Safety of Teriflunomide: An Analysis of Pooled Clinical Trials
Freedman, Mark
Inshasi, Jihad
Ramio-Torrenta, Lluis
Zaffaroni, Mauro
de Seze, Jerome
Ahn, Suk-won
Macdonell, Richard
Miller, Aaron
Kallmann, Boris
Rog, David
Benamor, Myriam
Truffinet, Philippe
Chavin, Jeffrey
Poole, Elizabeth
Lebrun-Frenay, Christine
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 51 - 51
[9] Long-term efficacy and safety of teriflunomide: an analysis of pooled clinical trials
Freedman, M. S.
Ramio-Torrenta, L.
Zaffaroni, M.
De Seze, J.
Ahn, S.
Macdonell, R.
Miller, A. E.
Kallmann, B.
Rog, D.
Benamor, M.
Truffinet, P.
Chavin, J.
Poole, E.
Lebrun-Frenay, C.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 700 - 701
[10] Pooled Analysis of RESOLUTE Clinical Trial Long-term Safety Data
Leon, Martin B.
Yeung, Alan
Serruys, Patrick W.
Meredith, Ian T.
Windecker, Stephan
Silber, Sigmund
Belardi, Jorge
Neumann, Franz-Joseph
Widimsky, Petr
Saito, Shigeru
Massaro, Joseph M.
Fajadet, Jean
Wijns, William
Mauri, Laura
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B23 - B23

← 1 2 3 4 5 →